Company intelligence / Profile preview

Tylon Pharma

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

Tylon Pharma has a diversified commercial portfolio, including APIs and finished formulations for numerous noncommunicable and infectious diseases, with particular strengths in generics, antiretroviral medicines, and contract manufacturing; specific clinical trial results not disclosed

Therapeutic areas: CardiovascularEndocrinologyGastroenterologyNeurologyInfectious DiseasesDermatologyOncology
Modalities: Small moleculeBiologicGeneric drugs
Industry: Biotech

Beyond the preview

Go deeper on Tylon Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tylon Pharma.

Explore the full profile